INTERNATIONAL PATENT: CELLTRION, INC., (주)셀트리온, ARUM THERAPEUTICS INC, (주)아름테라퓨틱스 FILES APPLICATION FOR "NOVEL OREXIN 2 RECEPTOR AGONIST AND USE THEREOF"

GENEVA, Jan. 27 -- CELLTRION, INC. (23 Academy-ro,Yeonsu-gu,Incheon 22014), (주)셀트리온 (인천광역시연수구아카데미로 23), ARUM THERAPEUTICS INC (301-ho, 38 Magokjungang 8-ro 1-gil,Gangseo-gu,Seoul 07793), (주)아름테라퓨틱스 (서울특별시강서구마곡중앙8로 1길 38, 301호) filed a patent application (PCT/KR2025/010662) for "NOVEL OREXIN 2 RECEPTOR AGONIST AND USE THEREOF" on Jul 18, 2025. With publication no. WO/2026/019302, the details related to the patent application was published on Jan 22, 2026.

Not...